SymBio Pharmaceuticals
Tokyo
About SymBio Pharmaceuticals
SymBio Pharmaceuticals operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $745.9M
- Funding stage: IPO
- Last round: Post-IPO Debt (Apr 2016)
- Ticker: tyo:4582
- Website: symbiopharma.com
- Phone: +81 354721125
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/symbio-pharmaceuticals-2232648 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.